Showing results (91-100 of 130) with videos related to

Sort By:
Pageof 13
Pharmacology Research & Perspectives|June 23, 2020
A multicenter, phase I, pharmacokinetic study of osimertinib in cancer patients with normal renal function or severe renal impairmentKarthick Vishwanathan, Inmaculada Sanchez-Simon, Bhumsuk Keam, et al.
Pharmaceutical Research|March 23, 2012
Pharmacokinetic-pharmacodynamic modeling of the D₂ and 5-HT (2A) receptor occupancy of risperidone and paliperidone in ratsMagdalena Kozielska, Martin Johnson, Venkatesh Pilla Reddy, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 16, 2019
Pharmacokinetic Study of Osimertinib in Cancer Patients with Mild or Moderate Hepatic ImpairmentEnrique Grande, R Donald Harvey, Benoit You, et al.
Pharmaceutical Research|June 8, 2011
Mechanism-based pharmacokinetic-pharmacodynamic modeling of the dopamine D2 receptor occupancy of olanzapine in ratsMartin Johnson, Magdalena Kozielska, Venkatesh Pilla Reddy, et al.
Current Medical Research and Opinion|November 26, 2005
Do strong opioids have a role in the early management of back pain? Recommendations from a European expert panelEija Kalso, Laurie Allan, Jan Dobrogowski, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 10, 2003
Neuronal repellent Slit2 inhibits dendritic cell migration and the development of immune responsesHongbing Guan, Guorui Zu, Yi Xie, et al.
Pharmaceutical Research|May 6, 2014
Dopamine D2 receptor occupancy as a predictor of catalepsy in rats: a pharmacokinetic-pharmacodynamic modeling approachMartin Johnson, Magdalena Kozielska, Venkatesh Pilla Reddy, et al.
Schizophrenia Research|March 12, 2013
Pharmacokinetic-pharmacodynamic modelling of antipsychotic drugs in patients with schizophrenia: part II: the use of subscales of the PANSS scoreVenkatesh Pilla Reddy, Magdalena Kozielska, Ahmed Abbas Suleiman, et al.
Pageof 13